Skip to main content
Article
Prognostic Utility of Immunoprofiling in Colon Cancer: Results from a Prospective, Multicenter Nodal Ultrastaging Trial.
Journal of The American College of Surgeons (2016)
  • Devin C. Flaherty, Department of Surgical Oncology, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA
  • Simon Lavotshkin, Department of Surgical Oncology, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA
  • John R. Jalas, Department of Pathology, Providence Saint John's Health Center, Santa Monica, CA
  • Hitoe Torisu-Itakura, Melanoma Research Program and Department of Immunology, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA
  • Daniel D. Kirchoff, Department of Surgical Oncology, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA
  • Myung S. Sim, University of California, Los Angeles
  • Delphine J. Lee, Dirks/Dougherty Laboratory for Cancer Research and Department of Translational Immunology, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA
  • Anton J. Bilchik, University of California, Los Angeles
Publication Date
July 1, 2016
DOI
10.1016/j.jamcollsurg.2016.03.003
Citation Information
Devin C. Flaherty, Simon Lavotshkin, John R. Jalas, Hitoe Torisu-Itakura, et al.. "Prognostic Utility of Immunoprofiling in Colon Cancer: Results from a Prospective, Multicenter Nodal Ultrastaging Trial." Journal of The American College of Surgeons Vol. 223 Iss. 1 (2016) p. 134 - 140
Available at: http://works.bepress.com/antonj-bilchik/21/